Iradimed (IRMD) Payables (2013 - 2026)

Iradimed (IRMD) has reported Payables for 14 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 2.73% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a 2.73% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 4.01% from the prior year.
• Payables was $1.8 million for Q2 2026 at Iradimed, down from $2.2 million in the prior quarter.
• Over five years, Payables peaked at $9.8 million in Q4 2023 and troughed at $822118.0 in Q2 2022.
• A 5-year average of $2.2 million and a median of $1.8 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables soared 446.49% in 2023 and plunged 80.72% in 2024, its largest moves.
• Over 5 years, Payables stood at $1.8 million in 2022, then soared by 446.49% to $9.8 million in 2023, then sank by 80.72% to $1.9 million in 2024, then fell by 4.01% to $1.8 million in 2025, then increased by 1.59% to $1.8 million in 2026.
• The last three Payables figures came in at $1.8 million (Q2 2026), $2.2 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.